Senate backers of deal to stabilize Obamacare seek to build support
WASHINGTON - Proponents of a bipartisan deal struck by two U.S. senators to stabilize Obamacare were seeking on Wednesday to win Republican support for the measure, which would restore subsidies to health insurers that President Donald Trump has scrapped.
Eli Lilly to collaborate with Germany's CureVac on cancer vaccines
- U.S. drugmaker Eli Lilly and Co said on Wednesday it will collaborate with CureVac AG on development of up to five immunotherapy cancer vaccines using the German company's messenger RNA technology.
Shanghai Pharma bids for U.S. Cardinal Health's China business
HONG KONG - Shanghai Pharmaceuticals Holding Co has bid for Cardinal Health Inc's China business as the U.S. company looks to sell ahead of China's planned drug distribution reform.
Alnyalm, Vir partner on RNAi-based drugs for infectious diseases
- Drug developer Alnylam Pharmaceuticals Inc entered into an agreement with privately held Vir Biotechnology on Wednesday to develop a new class of RNAi-based treatments for infectious diseases, including chronic hepatitis B.
Allergan ruling casts doubt on tribal patent strategy
- A U.S. judge's ruling on Monday invalidating Allergan Plc's patents on its blockbuster $1.5 billion dry-eye medicine, Restasis, has cast doubt on the company's novel strategy to enlist a Native American tribe to help shield those patents from challenge by generic drugmakers, legal experts ...
Johnson & Johnson wins reversal of $72 million verdict over talc cancer risks
- Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company's talc-based products like Johnson's Baby Powder.
Astra and Merck win speedy review for Lynparza in breast cancer
LONDON - U.S. regulators have granted a priority review to AstraZeneca's ovarian cancer drug Lynparza as a treatment for breast cancer, putting it on track for potential approval in the new disease area during the first quarter of 2018.
Novartis says ā€¨revolade shows long-term disease control for chronic/persistent immune thrombocytopeniaā€‹
ZURICH - Novartis said on Wednesday a long term study of ā€¨its Revolade drug showed good results in treating chronic and persistent immune thrombocytopenia - a condition where patients' blood does not clot normally.
Florida needs more pet-friendly hurricane shelters for the elderly
- When pet owners need to flee from disasters like hurricanes and fires, they often think first of their animals, but a new study suggests a scarcity of pet-friendly emergency shelters could make older evacuees all the more vulnerable.
Should donor sex influence blood transfusion practices?
- Sick or injured men who receive blood transfusions may be more likely to die if their donor was a woman who has been pregnant in the past, a new study suggests.
UnitedHealth sees growth in 2018, opportunities in Trump plans
- UnitedHealth Group Inc, the largest U.S. health insurer, said earnings will grow 13 to 16 percent in 2018 as medical costs remain low, and that it expects to benefit from new insurance products backed by U.S. President Donald Trump.
New cancer drugs help J&J top profit estimates
- Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast as the company gained from strong sales of its new cancer drugs.
China confirms bird flu outbreak at poultry farms in central province
BEIJING - China on Tuesday confirmed an outbreak of bird flu at broiler chicken farms in a central province, the Ministry of Agriculture said in a statement.
Japan's "Blade Library" offers joy of blade running to amputees
TOKYO - Haruta Saito, a young Japanese amputee who dreams of becoming a Paralympian, remembers strapping on a prosthetic "running blade" for the first time.
Regeneron-Sanofi drug succeeds mid-stage study
- Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.
Chi-Med, AstraZeneca lung cancer drug shrinks resistant tumors
LONDON - An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines.
Aimmune teams with Regeneron, Sanofi on peanut allergy drug
- Aimmune Therapeutics Inc said on Monday it would collaborate with Regeneron Pharmaceuticals Inc and Sanofi to develop its experimental peanut allergy drug.
More men than women infected with oral human papillomavirus
- Roughly one in nine U.S. men have oral infections of the cancer-causing human papillomavirus , more than triple the infection rate for women, a new study suggests.
Exelixis drug improves overall survival in liver cancer patients
- Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent.
Some mothers may not seek early help for kids with developmental delays
- When mothers trust their friends and neighbors more than doctors or struggle to access or afford care, they may be less likely to seek out medical help for young kids with developmental delays, a small U.S. study suggests.
Intensive resistance training safe, effective for women with osteoporosis
- High-intensity resistance and impact training may improve bone and muscle strength in select postmenopausal women with osteoporosis, according to a small study in Australia.
U.S. judge in Texas invalidates Allergan patents on Restasis
- A U.S. judge on Monday invalidated patents on Allergan Plc's dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious, sending shares of the pharmaceutical company down 3.5 percent.
Uruguay to produce medical marijuana for export
MONTEVIDEO - International Cannabis Corporation will produce Uruguay's first batch of medical cannabis oil for export in December, the company's chief executive said Sunday.
Madagascar plague appears to have spread to Seychelles: WHO
GENEVA - A probable case of plague in the Seychelles, imported from Madagascar, is believed to have sparked the Indian Ocean country's first outbreak of the disease, the World Health Organization said.
Novo Nordisk diabetes drug effective, preliminary FDA review finds
- Novo Nordisk A/S's closely watched diabetes drug semaglutide is effective, a preliminary review by the U.S. Food and Drug Administration concluded, sending the company's shares up 3.4 percent in premarket trading on Monday.
Regeneron-Sanofi food allergy drug succeeds mid-stage study
- Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat infection in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.
Exelixis liver cancer drug meets late-stage goal, shares jump
- Exelixis Inc said on Monday its drug to treat patients with a type of liver cancer met the main goal in a late stage study, pushing it closer to an expanded label approval by U.S. regulators and sending its shares up about 20 percent.
BrainStorm enrolls first patients in advanced ALS stem cell trial
TEL AVIV - BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis at Massachusetts General Hospital and UC Irvine Medical Center in California.
GlaxoSmithKline's shingles vaccine gets approval in Canada
- Canadian health regulators have approved GlaxoSmithKline's key shingles vaccine, the company said on Friday.
J&J psoriasis drug gets expanded U.S. approval for teens
- Johnson & Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients aged 12 and over with moderate to severe cases of the unsightly skin condition.
Aspirin habits unchanged by recommendations from U.S. doctors
- U.S. guidelines urging more adults who never had a heart attack or stroke to take a daily aspirin may not have convinced people to take these pills, a recent study suggests.
After medical errors, patients want doctors to hear them out
- When medical errors lead to serious injuries, patients and families may feel better when doctors take the time to listen to their feelings about the mistake and explain what can be done to prevent it from happening again, a small study suggests.
WHO says attack on Syria vaccine store leaves children at risk
LONDON - The World Health Organization said on Friday it had received reports of an attack on medical facilities in eastern Syria that had destroyed a store containing more than 130,000 vaccine doses against measles and polio.
Milan hopes to gain from Barcelona's pain in race for EU drugs agency
MILAN - Milan is hoping that Spain's Catalonia crisis will give the Italian city a boost in getting to host the European Medicines Agency , the European Union agency quitting London because of Brexit.
Little evidence new cancer drugs improve survival
- There's not much evidence to show that most new cancer drugs approved in Europe in recent years can help patients live longer or improve their quality of life, a recent study suggests.
U.S. FDA panel backs Aerie's glaucoma drug Rhopressa
- Aerie Pharmaceuticals Inc's experimental glaucoma treatment should be approved, an advisory committee to the U.S. Food and Drug Administration said on Friday, after it found the benefits outweigh the risks.
Roche's Alecensa wins EU panel's nod against mutated lung cancer
ZURICH - Swiss drugmaker Roche's Alecensa has been recommended for approval in Europe as a first-line treatment for mutated lung cancer, a key European Medicines Agency experts panel said on Friday.
Sanofi boosts vaccines business with 170 million euro investment
VAL-DE-REUIL, France - Sanofi on Thursday expressed confidence in the growth of its influenza vaccines after committing to invest 170 million euros to expand its manufacturing facility at Val-de-Reuil in north-western France.
Allergan settles with one of four companies contesting Restasis patent
- Allergan Plc said on Thursday it reached a settlement with InnoPharma Inc, one of the four generic drugmakers challenging the patents for its dry eye medication Restasis in federal court.
Trump's not-so-quick fix to undo Obamacare
NEW YORK - President Donald Trump on Thursday prescribed a quick fix to undo Obamacare through executive order after Republicans in the U.S. Congress failed to repeal and replace the healthcare law as promised, but industry experts said there are many steps involved that will slow it down.
FDA panel backs gene therapy for rare form of blindness
- Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.
Cardiac arrest survival odds may rise with public CPR training
- Training more community members, patients and families to recognize and respond to a cardiac arrest before medical help arrives may help more victims survive, a U.S. study suggests.
After concussion, teen girls may take longer to heal than boys
- Female adolescent athletes may take more than twice as long to recover from concussions as their male counterparts, a small study suggests.
Trump healthcare order could run afoul of retirement plan law
- President Donald Trump's plan to make it easier for small businesses to band together and buy stripped-down health insurance plans could violate a federal law governing employee benefit plans and will almost certainly be challenged in court, legal experts said.
U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research
- The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer.
AcelRx Pharma shares sink as FDA rejects opioid painkiller
- Shares of AcelRx Pharmaceuticals Inc plunged more than 60 percent on Thursday after the U.S. Food and Drug Administration declined to approve its opioid painkiller Dsuvia.
'Double whammy' for Roche as manufacturing patent losses loom
ZURICH - Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income for the Swiss drugmaker and piling pressure on its new medicines to succeed.
AcelRx Pharma shares sink as FDA rejects its opioid painkiller
- AcelRx Pharmaceuticals Inc's shares plunged more than 60 percent before the bell on Thursday after the U.S. Food and Drug Administration rejected the drugmaker's opioid painkiller in its present form.
Swedish prosecutor says will not charge Italian stem cell surgeon
STOCKHOLM - Swedish prosecutors said on Thursday they were ending without charges an investigation into surgeon Paolo Macchiarini after finding no legal evidence he caused the death of three patients.
Merck says will not seek approval of cholesterol treatment
- Merck & Co Inc said on Wednesday it will not seek regulatory approval for its experimental cholesterol drug, anacetrapib, as the clinical profile of the treatment does not support regulatory filings.